INTRODUCTION

B lastomycosis is caused by a dimorphic fungus
Blastomyces dermatitidis. Recently, a few cases have been reported from India. [1] Only 3-11% of all reported cases are aged <20 years. [1] Cutaneous forms are almost always secondary to pulmonary disease. [1] We report a rare fatal case of disseminated cutaneous blastomycosis without pulmonary involvement in pediatric age group.
CASE REPORT
A 12-year-old boy presented to the casualty with 8 months history of multiple, verrucous, hyperkeratotic, and suppurating plaques over the face, chest, and limbs. At the time of admission, there were multiple hyperkeratotic and scaly plaques of varying sizes on the face, neck, chest, hands, and legs. His lesions started as a plaque on the left knee joint which did not respond to Anti tubercular treatment. At the time of admission, person. His reflexes were normal. His blood culture was negative, but pus culture showed heavy growth of Escherichia coli. Hemogram revealed a low hemoglobin of 6.6 g/dl, total leukocyte count of 25,500/ mm 3 , differential leukocytes count of neutrophils 87%, lymphocytes 13%, platelet count 530,000/ mm 3 , erythrocyte sedimentation rate 40 mm/h, serum alkaline phosphatase 129 IU/L, serum glutamate pyruvate transaminase18 IU/L, serum glutamate-oxaloacetate transaminase 38 IU/L, serum proteins 4.6 g/dl, albumin 1.4 g/dl, albumin/globulin ratio 0.4, serum uric acid 9.7 mg/dl, blood urea nitrogen 23 mg/dl, serum sodium 114 mmol/L and serum potassium 4.8 mmol/L. HIV test was negative. Chest radiograph revealed normal radiographic findings. Cerebrospinal fluid obtained from lumbar puncture was within normal limits; Koh mount showed broad-based budding organisms on tissue scrapings from ulcer margins. Gram staining showed Gram-negative cocci. Blood culture was sterile. Provisional clinical diagnosis of blastomycosis was confirmed by histopathology report. Thereafter, an aggressive treatment was started to control the disseminated blastomycosis. The patient was started on oral itraconazole 5 mg/kg/day. Intravenous (I.V.) cefoperazone and sulbactam combination was started at the dose 20 mg/kg/day along with I.V. vancomycin 3 mg/kg/day dose. His skin lesions improved. He was also given three packed blood transfusions over a period of 7 days. The child lost consciousness on the 4 th day when he was started on injection amphotericin B 5 mg/kg/body weight. Unfortunately, he succumbed to death on the day 15 th of admission.
DISCUSSION
Blastomycosis is a relatively uncommon chronic granulomatous disease even in the endemic regions, more so in India. It is rarely diagnosed in children. In children, lung involvement is followed by skin, bone, and central nervous system (CNS) in descending order of incidence. [2] However, in the present case, there was no lung involvement. Diagnostic delays are not Primary cutaneous blastomycosis has infrequently been reported after dog bites also; such patients may not disease clinically active pulmonary as in our present case. [3] However, the parents denied any history of dog bite in the present patient.
Blastomycosis is caused by inhalation of conidia of dimorphic fungi B. dermatitidis although direct inoculation can occur. Skin is the most frequent site (40-80%) of dissemination of pulmonary blastomycosis followed by bone (10-50%), genitourinary tract (10-30%), and CNS (1-5%). [4] In our case, skin seems to be the primary site of inoculation. Disseminated blastomycosis occurs more frequently in immunocompromised individuals. To the best of our knowledge, this is the second case of disseminated blastomycosis from India in pediatric age group. [5] In our case, there was no lung and CNS involvement and disease appeared limited to skin. [3] Diagnosis of blastomycosis may be confirmed through identification of yeasts of B. dermatitidis in body fluids and tissues. Although culture is the gold standard method for the detecting fungus, it is positive in only 3.2% cases. [2] Even in the absence of positive culture, the case can be diagnosed by histopathological examination and fine needle aspiration cytology of the lesions. [1] Yeast forms can be seen in hematoxylin and eosin-stained sections but are better visualized by methenamine silver stain or PAS stain. [1] For children with mild to moderate infection, oral itraconazole, at a dosage of 10 mg/kg/day (to a maximum of 400 mg orally per day) for 6-12 months, is recommended. [6] Serum levels of itraconazole should be determined after the patient has received this agent for at least 2 weeks to ensure adequate drug exposure. [6] For children with severe blastomycosis, lipid formulation AmB, at a dosage of 3-5 mg/kg/day, is recommended for initial therapy. [6] Itraconazole, 10 mg/kg/day (up to 400 mg per day) as step-down therapy, is recommended for a total of 12 months. [6] Despite antifungal therapy, the mortality rate of blastomycosis associated acute respiratory distress syndrome is still 50-89%. [7] CONCLUSION Early detection and diagnosis of a suspected case of blastomycosis and prompt treatment with antifungal agents are the key to the successful management of blastomycosis. This case is being reported for its rarity and the fact that dissemination over skin may appear without any lung involvement in pediatric age group.
